Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_assertion type Assertion NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_head.
- NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_assertion description "[Thus, NF-kappaB inhibitors may open new perspectives to potentiate the efficacy of TRAIL-based protocols in the treatment of neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_provenance.
- NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_assertion evidence source_evidence_literature NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_provenance.
- NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_assertion SIO_000772 19065652 NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_provenance.
- NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_assertion wasDerivedFrom befree-20140225 NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_provenance.
- NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_assertion wasGeneratedBy ECO_0000203 NP217333.RA-DCUhxQQ3Yk_irI_RyCnpVw8_pF9st5kJPc4uf63MD8130_provenance.